Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiosurgery | 12 | 2023 | 1354 | 1.080 |
Why?
|
Brain Neoplasms | 25 | 2024 | 9182 | 1.040 |
Why?
|
Cranial Irradiation | 5 | 2020 | 395 | 0.850 |
Why?
|
Carcinoma, Renal Cell | 13 | 2024 | 3197 | 0.840 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 47 | 2024 | 11843 | 0.840 |
Why?
|
Fluorouracil | 25 | 2023 | 1656 | 0.790 |
Why?
|
Abnormalities, Drug-Induced | 7 | 2012 | 341 | 0.710 |
Why?
|
Toxicology | 4 | 2012 | 104 | 0.610 |
Why?
|
Neoplasm Recurrence, Local | 28 | 2024 | 9425 | 0.560 |
Why?
|
Lung Neoplasms | 21 | 2022 | 13589 | 0.540 |
Why?
|
Kidney Neoplasms | 10 | 2024 | 4298 | 0.530 |
Why?
|
Colorectal Neoplasms | 17 | 2024 | 6978 | 0.510 |
Why?
|
Adenocarcinoma | 19 | 2019 | 6400 | 0.510 |
Why?
|
Carcinoma, Squamous Cell | 11 | 2019 | 4083 | 0.440 |
Why?
|
Pancreatic Neoplasms | 13 | 2023 | 5442 | 0.430 |
Why?
|
Paclitaxel | 9 | 2023 | 1737 | 0.430 |
Why?
|
Colonic Neoplasms | 16 | 2022 | 2544 | 0.420 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 9 | 2022 | 5426 | 0.420 |
Why?
|
Ozone | 7 | 2006 | 490 | 0.410 |
Why?
|
Models, Statistical | 13 | 2023 | 5103 | 0.390 |
Why?
|
Oropharyngeal Neoplasms | 4 | 2019 | 493 | 0.380 |
Why?
|
Toxicity Tests | 2 | 2005 | 114 | 0.380 |
Why?
|
Deoxycytidine | 7 | 2018 | 888 | 0.370 |
Why?
|
Neoplasm Staging | 32 | 2022 | 11249 | 0.360 |
Why?
|
Radiotherapy, Intensity-Modulated | 6 | 2022 | 811 | 0.360 |
Why?
|
Cranial Nerve Neoplasms | 3 | 1996 | 134 | 0.350 |
Why?
|
Esophageal Neoplasms | 5 | 2023 | 1676 | 0.350 |
Why?
|
Aged | 117 | 2024 | 171520 | 0.350 |
Why?
|
Posture | 4 | 2016 | 956 | 0.330 |
Why?
|
Radiotherapy, Adjuvant | 6 | 2020 | 1794 | 0.330 |
Why?
|
Radiation Injuries | 4 | 2018 | 1205 | 0.330 |
Why?
|
Middle Aged | 123 | 2024 | 223418 | 0.320 |
Why?
|
Air Pollution, Indoor | 9 | 2019 | 914 | 0.320 |
Why?
|
Disease-Free Survival | 25 | 2022 | 6856 | 0.320 |
Why?
|
Female | 157 | 2024 | 396943 | 0.310 |
Why?
|
Humans | 219 | 2024 | 768451 | 0.310 |
Why?
|
Antineoplastic Agents, Phytogenic | 6 | 2015 | 624 | 0.300 |
Why?
|
Fetal Death | 3 | 1994 | 438 | 0.300 |
Why?
|
Computers | 4 | 2016 | 592 | 0.300 |
Why?
|
Papillomaviridae | 4 | 2019 | 1135 | 0.290 |
Why?
|
Food Services | 3 | 2016 | 209 | 0.290 |
Why?
|
Risk Assessment | 13 | 2020 | 24311 | 0.280 |
Why?
|
Leucovorin | 12 | 2023 | 643 | 0.280 |
Why?
|
Air Pollutants | 12 | 2006 | 2905 | 0.280 |
Why?
|
Liver Neoplasms | 9 | 2021 | 4362 | 0.280 |
Why?
|
Stomach Neoplasms | 5 | 2023 | 1484 | 0.280 |
Why?
|
Dose-Response Relationship, Drug | 20 | 2016 | 10784 | 0.270 |
Why?
|
Anus Neoplasms | 3 | 2022 | 338 | 0.270 |
Why?
|
Salvage Therapy | 6 | 2023 | 1277 | 0.270 |
Why?
|
Vestibulocochlear Nerve | 2 | 1996 | 115 | 0.270 |
Why?
|
Vaginal Neoplasms | 2 | 2017 | 105 | 0.260 |
Why?
|
Antimetabolites, Antineoplastic | 8 | 2017 | 647 | 0.260 |
Why?
|
Neuroendocrine Tumors | 2 | 2022 | 649 | 0.260 |
Why?
|
Male | 131 | 2024 | 364781 | 0.260 |
Why?
|
Aged, 80 and over | 49 | 2024 | 59680 | 0.260 |
Why?
|
Meningeal Neoplasms | 3 | 2023 | 1251 | 0.260 |
Why?
|
Head and Neck Neoplasms | 7 | 2023 | 2915 | 0.250 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 4 | 2020 | 1680 | 0.250 |
Why?
|
SEER Program | 8 | 2020 | 1476 | 0.250 |
Why?
|
Adult | 95 | 2024 | 223542 | 0.250 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2020 | 331 | 0.240 |
Why?
|
Brachytherapy | 3 | 2017 | 1227 | 0.240 |
Why?
|
Neuroma, Acoustic | 3 | 2000 | 458 | 0.240 |
Why?
|
Breast Neoplasms | 11 | 2024 | 21156 | 0.230 |
Why?
|
Prognosis | 27 | 2024 | 30028 | 0.230 |
Why?
|
Workplace | 4 | 2019 | 872 | 0.230 |
Why?
|
Cryosurgery | 3 | 2014 | 477 | 0.220 |
Why?
|
Temporal Muscle | 1 | 2023 | 36 | 0.220 |
Why?
|
Retrospective Studies | 47 | 2024 | 81834 | 0.220 |
Why?
|
Neoplasm Metastasis | 9 | 2022 | 4931 | 0.220 |
Why?
|
Mastectomy | 3 | 2019 | 1852 | 0.220 |
Why?
|
Teratogens | 4 | 2000 | 117 | 0.220 |
Why?
|
Growth Charts | 1 | 2023 | 60 | 0.210 |
Why?
|
Environmental Exposure | 10 | 2007 | 4533 | 0.210 |
Why?
|
Temporal Bone | 2 | 2001 | 683 | 0.210 |
Why?
|
Likelihood Functions | 3 | 2005 | 993 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 13 | 2020 | 6537 | 0.210 |
Why?
|
Radiotherapy Dosage | 10 | 2024 | 2925 | 0.210 |
Why?
|
Cannabidiol | 1 | 2024 | 123 | 0.210 |
Why?
|
Melanoma | 4 | 2024 | 5740 | 0.200 |
Why?
|
Facility Design and Construction | 2 | 2019 | 85 | 0.200 |
Why?
|
Treatment Outcome | 50 | 2023 | 65409 | 0.200 |
Why?
|
Endometrial Neoplasms | 3 | 2017 | 1382 | 0.200 |
Why?
|
Thymidylate Synthase | 2 | 2017 | 74 | 0.200 |
Why?
|
Housing | 5 | 2015 | 679 | 0.200 |
Why?
|
Rectal Neoplasms | 4 | 2019 | 1179 | 0.200 |
Why?
|
Chemotherapy, Adjuvant | 14 | 2022 | 3550 | 0.190 |
Why?
|
Particle Size | 11 | 2015 | 1654 | 0.190 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2022 | 137 | 0.190 |
Why?
|
Stereotaxic Techniques | 2 | 2020 | 556 | 0.190 |
Why?
|
Survival Analysis | 20 | 2020 | 10125 | 0.190 |
Why?
|
Cranial Nerve Injuries | 1 | 2001 | 28 | 0.190 |
Why?
|
Models, Theoretical | 7 | 2015 | 3590 | 0.190 |
Why?
|
Glomus Jugulare Tumor | 1 | 2001 | 35 | 0.190 |
Why?
|
Nature | 1 | 2021 | 15 | 0.190 |
Why?
|
Spinal Cord Neoplasms | 1 | 2023 | 263 | 0.180 |
Why?
|
Food Preferences | 2 | 2015 | 399 | 0.180 |
Why?
|
Lymphatic Metastasis | 7 | 2015 | 2930 | 0.180 |
Why?
|
Teratology | 1 | 2000 | 8 | 0.180 |
Why?
|
Carcinoma, Basal Cell | 3 | 2007 | 564 | 0.180 |
Why?
|
Survival Rate | 17 | 2020 | 12875 | 0.180 |
Why?
|
Receptors, KIR | 1 | 2020 | 114 | 0.180 |
Why?
|
Skull Base | 2 | 2001 | 294 | 0.170 |
Why?
|
Ependymoma | 1 | 2023 | 324 | 0.170 |
Why?
|
Radiation Oncology | 2 | 2020 | 573 | 0.170 |
Why?
|
Skull Neoplasms | 1 | 2001 | 173 | 0.170 |
Why?
|
Dust | 2 | 2006 | 488 | 0.170 |
Why?
|
Antineoplastic Agents | 12 | 2019 | 13708 | 0.170 |
Why?
|
Combined Modality Therapy | 16 | 2019 | 8559 | 0.170 |
Why?
|
Task Performance and Analysis | 2 | 2014 | 771 | 0.170 |
Why?
|
Rectum | 2 | 2015 | 902 | 0.170 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2000 | 87 | 0.170 |
Why?
|
Endogenous Retroviruses | 1 | 2020 | 112 | 0.170 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2005 | 716 | 0.160 |
Why?
|
Memantine | 1 | 2020 | 111 | 0.160 |
Why?
|
Neoplasm Seeding | 1 | 2019 | 85 | 0.160 |
Why?
|
Clinical Trials, Phase III as Topic | 4 | 2018 | 876 | 0.160 |
Why?
|
Extreme Heat | 1 | 2019 | 60 | 0.150 |
Why?
|
Nanoparticles | 4 | 2015 | 1986 | 0.150 |
Why?
|
Otologic Surgical Procedures | 1 | 2000 | 150 | 0.150 |
Why?
|
Regression Analysis | 7 | 2015 | 6353 | 0.150 |
Why?
|
Sarcopenia | 1 | 2023 | 376 | 0.150 |
Why?
|
Skin Neoplasms | 5 | 2020 | 5891 | 0.150 |
Why?
|
Police | 1 | 2020 | 157 | 0.150 |
Why?
|
Public Housing | 1 | 2019 | 140 | 0.150 |
Why?
|
Schools | 3 | 2016 | 1496 | 0.150 |
Why?
|
Clinical Trials as Topic | 5 | 2020 | 8051 | 0.150 |
Why?
|
Registries | 2 | 2018 | 8373 | 0.150 |
Why?
|
Collagen Diseases | 1 | 2017 | 39 | 0.150 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2020 | 452 | 0.150 |
Why?
|
Neurosurgical Procedures | 2 | 2019 | 2097 | 0.150 |
Why?
|
Reward | 2 | 2016 | 987 | 0.150 |
Why?
|
Hospices | 1 | 2020 | 245 | 0.140 |
Why?
|
Prescriptions | 1 | 2020 | 387 | 0.140 |
Why?
|
Follow-Up Studies | 26 | 2020 | 39430 | 0.140 |
Why?
|
Immunoglobulins | 1 | 2020 | 856 | 0.140 |
Why?
|
Equipment and Supplies | 1 | 2020 | 273 | 0.140 |
Why?
|
Anxiety | 2 | 2024 | 4655 | 0.140 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 2 | 2007 | 13 | 0.140 |
Why?
|
Food Supply | 2 | 2013 | 543 | 0.140 |
Why?
|
Carcinoma | 4 | 2012 | 2341 | 0.140 |
Why?
|
Models, Biological | 7 | 2014 | 9505 | 0.140 |
Why?
|
Viral Envelope Proteins | 1 | 2020 | 641 | 0.140 |
Why?
|
Radiation Pneumonitis | 1 | 2017 | 103 | 0.140 |
Why?
|
Papillomavirus Infections | 3 | 2019 | 1638 | 0.140 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2021 | 2048 | 0.140 |
Why?
|
Xenobiotics | 1 | 1997 | 71 | 0.140 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 2022 | 637 | 0.140 |
Why?
|
Research Subjects | 1 | 2018 | 249 | 0.140 |
Why?
|
Financial Management | 1 | 2018 | 161 | 0.130 |
Why?
|
Hot Temperature | 2 | 2020 | 1439 | 0.130 |
Why?
|
Neoplasms | 8 | 2020 | 22386 | 0.130 |
Why?
|
Prospective Studies | 21 | 2024 | 54914 | 0.130 |
Why?
|
Germinoma | 3 | 2003 | 132 | 0.130 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2016 | 66 | 0.130 |
Why?
|
Organoplatinum Compounds | 6 | 2019 | 408 | 0.130 |
Why?
|
Linear Models | 5 | 2018 | 5880 | 0.130 |
Why?
|
Biometry | 3 | 2006 | 565 | 0.130 |
Why?
|
Ear Neoplasms | 1 | 1996 | 118 | 0.130 |
Why?
|
Oxidants, Photochemical | 3 | 2002 | 77 | 0.130 |
Why?
|
Cisplatin | 8 | 2015 | 1661 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2015 | 1376 | 0.130 |
Why?
|
Microsurgery | 2 | 2001 | 803 | 0.130 |
Why?
|
Albumins | 1 | 2018 | 578 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2024 | 1265 | 0.130 |
Why?
|
Environment | 3 | 2019 | 1126 | 0.130 |
Why?
|
Facial Nerve Diseases | 1 | 1995 | 49 | 0.130 |
Why?
|
Psychophysics | 1 | 2016 | 291 | 0.120 |
Why?
|
Doxorubicin | 7 | 2020 | 2229 | 0.120 |
Why?
|
Vestibular Nerve | 1 | 1995 | 101 | 0.120 |
Why?
|
Epidural Neoplasms | 1 | 1995 | 24 | 0.120 |
Why?
|
Pinocytosis | 1 | 2015 | 63 | 0.120 |
Why?
|
Microwaves | 1 | 2016 | 184 | 0.120 |
Why?
|
Esophagogastric Junction | 2 | 2023 | 349 | 0.120 |
Why?
|
Anilides | 1 | 2018 | 415 | 0.120 |
Why?
|
Bayes Theorem | 2 | 2017 | 2358 | 0.120 |
Why?
|
Proportional Hazards Models | 11 | 2023 | 12561 | 0.120 |
Why?
|
Waste Products | 1 | 2014 | 12 | 0.120 |
Why?
|
Accidents, Occupational | 1 | 2016 | 252 | 0.120 |
Why?
|
Glioblastoma | 2 | 2023 | 3523 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 11 | 2022 | 10358 | 0.120 |
Why?
|
Myoglobinuria | 1 | 2014 | 22 | 0.120 |
Why?
|
Health Resources | 1 | 2020 | 950 | 0.120 |
Why?
|
Radiotherapy | 5 | 2015 | 1510 | 0.110 |
Why?
|
Thoracoscopy | 1 | 2015 | 186 | 0.110 |
Why?
|
Neoadjuvant Therapy | 4 | 2018 | 2896 | 0.110 |
Why?
|
Intraoperative Complications | 1 | 2001 | 1176 | 0.110 |
Why?
|
Trigeminal Nerve | 1 | 1995 | 248 | 0.110 |
Why?
|
Mastectomy, Segmental | 3 | 2016 | 961 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1166 | 0.110 |
Why?
|
Drug Administration Schedule | 9 | 2019 | 4861 | 0.110 |
Why?
|
Vertebral Artery | 1 | 1995 | 186 | 0.110 |
Why?
|
Vulvar Neoplasms | 1 | 2016 | 267 | 0.110 |
Why?
|
Cysts | 1 | 2019 | 685 | 0.110 |
Why?
|
Tinnitus | 1 | 1996 | 197 | 0.110 |
Why?
|
Hazardous Substances | 1 | 1994 | 153 | 0.110 |
Why?
|
Ablation Techniques | 1 | 2016 | 249 | 0.110 |
Why?
|
Computer Peripherals | 1 | 2013 | 38 | 0.110 |
Why?
|
Radiology, Interventional | 1 | 2017 | 477 | 0.110 |
Why?
|
Cholangiocarcinoma | 1 | 2018 | 563 | 0.110 |
Why?
|
Bile Duct Neoplasms | 1 | 2018 | 617 | 0.110 |
Why?
|
Arm | 1 | 2016 | 590 | 0.110 |
Why?
|
Craniotomy | 2 | 1994 | 748 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 712 | 0.100 |
Why?
|
Occupational Health | 1 | 2019 | 814 | 0.100 |
Why?
|
Spinal Cord Compression | 1 | 1995 | 234 | 0.100 |
Why?
|
Climate Change | 1 | 2019 | 510 | 0.100 |
Why?
|
Seminoma | 2 | 2012 | 136 | 0.100 |
Why?
|
Temperature | 1 | 2019 | 2237 | 0.100 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 1994 | 243 | 0.100 |
Why?
|
Lymph Nodes | 2 | 2015 | 3472 | 0.100 |
Why?
|
Pregnancy, Animal | 1 | 2012 | 124 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 1427 | 0.100 |
Why?
|
Shoulder Pain | 1 | 2013 | 152 | 0.100 |
Why?
|
Interviews as Topic | 2 | 2013 | 2733 | 0.100 |
Why?
|
Incidence | 10 | 2023 | 21552 | 0.100 |
Why?
|
Premenopause | 1 | 2016 | 1039 | 0.100 |
Why?
|
Air Pollution | 4 | 2006 | 2364 | 0.100 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2014 | 195 | 0.100 |
Why?
|
Odds Ratio | 9 | 2019 | 9687 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1409 | 0.100 |
Why?
|
Sphenoid Bone | 1 | 1993 | 177 | 0.100 |
Why?
|
United States | 21 | 2022 | 73121 | 0.100 |
Why?
|
Postoperative Complications | 7 | 2015 | 15880 | 0.100 |
Why?
|
Sarcoma | 1 | 2023 | 1806 | 0.100 |
Why?
|
Neck Pain | 1 | 2013 | 190 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 7 | 2024 | 36840 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2024 | 3520 | 0.100 |
Why?
|
Hearing | 1 | 1995 | 502 | 0.090 |
Why?
|
Research Design | 4 | 2014 | 6217 | 0.090 |
Why?
|
Thumb | 1 | 2013 | 232 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 9 | 2021 | 20762 | 0.090 |
Why?
|
Diet | 3 | 2014 | 8098 | 0.090 |
Why?
|
Esophagectomy | 1 | 2015 | 482 | 0.090 |
Why?
|
Rats | 9 | 2012 | 23839 | 0.090 |
Why?
|
Environmental Monitoring | 4 | 2007 | 1464 | 0.090 |
Why?
|
Medical Oncology | 4 | 2017 | 2347 | 0.090 |
Why?
|
Etoposide | 3 | 2003 | 640 | 0.090 |
Why?
|
Benchmarking | 3 | 2014 | 1058 | 0.090 |
Why?
|
Animals | 30 | 2023 | 169418 | 0.090 |
Why?
|
Microsatellite Repeats | 2 | 2005 | 784 | 0.090 |
Why?
|
Sulfonamides | 1 | 2020 | 1988 | 0.090 |
Why?
|
Pulmonary Fibrosis | 1 | 1995 | 507 | 0.090 |
Why?
|
Data Interpretation, Statistical | 4 | 2007 | 2705 | 0.090 |
Why?
|
Tumor Burden | 4 | 2018 | 1909 | 0.090 |
Why?
|
Poverty | 4 | 2019 | 2719 | 0.090 |
Why?
|
Veins | 1 | 1995 | 767 | 0.090 |
Why?
|
Therapies, Investigational | 1 | 2011 | 111 | 0.090 |
Why?
|
Safety Management | 1 | 2016 | 764 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 3 | 2022 | 5709 | 0.090 |
Why?
|
Fetus | 2 | 1999 | 1883 | 0.090 |
Why?
|
Pneumothorax | 1 | 2014 | 393 | 0.090 |
Why?
|
Hand Strength | 1 | 2013 | 465 | 0.090 |
Why?
|
Cumulative Trauma Disorders | 1 | 2012 | 153 | 0.090 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2016 | 617 | 0.090 |
Why?
|
Predictive Value of Tests | 9 | 2024 | 15460 | 0.090 |
Why?
|
Glycosuria | 1 | 2009 | 44 | 0.090 |
Why?
|
Infusions, Intravenous | 4 | 2009 | 2228 | 0.090 |
Why?
|
Neurilemmoma | 1 | 1995 | 524 | 0.090 |
Why?
|
Palliative Care | 5 | 2016 | 3644 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2014 | 2331 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 1104 | 0.080 |
Why?
|
Young Adult | 16 | 2024 | 60045 | 0.080 |
Why?
|
Pyrroles | 1 | 2016 | 1127 | 0.080 |
Why?
|
Diabetes Complications | 2 | 2009 | 1322 | 0.080 |
Why?
|
Airway Obstruction | 1 | 1995 | 672 | 0.080 |
Why?
|
Taxoids | 3 | 2016 | 669 | 0.080 |
Why?
|
Drug Therapy | 1 | 2012 | 504 | 0.080 |
Why?
|
Camptothecin | 4 | 2016 | 594 | 0.080 |
Why?
|
Multivariate Analysis | 7 | 2014 | 12096 | 0.080 |
Why?
|
Quality of Life | 6 | 2023 | 13497 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1058 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2017 | 1162 | 0.080 |
Why?
|
Catheter Ablation | 2 | 2014 | 2775 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4780 | 0.080 |
Why?
|
Lymph Node Excision | 4 | 2015 | 1276 | 0.080 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2016 | 1536 | 0.080 |
Why?
|
Durapatite | 2 | 2000 | 166 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2001 | 762 | 0.080 |
Why?
|
Ear, Inner | 1 | 1993 | 426 | 0.080 |
Why?
|
Lymphedema | 1 | 2015 | 527 | 0.080 |
Why?
|
Fetal Macrosomia | 1 | 2009 | 138 | 0.080 |
Why?
|
Behavior, Animal | 1 | 1997 | 1882 | 0.080 |
Why?
|
Chondrosarcoma | 1 | 2011 | 306 | 0.080 |
Why?
|
Leadership | 1 | 2018 | 1395 | 0.080 |
Why?
|
Mesothelioma | 1 | 2015 | 811 | 0.080 |
Why?
|
Postural Balance | 1 | 2013 | 638 | 0.080 |
Why?
|
Headache | 1 | 1996 | 1260 | 0.080 |
Why?
|
Inhalation Exposure | 3 | 2000 | 433 | 0.080 |
Why?
|
Gastrectomy | 1 | 2013 | 696 | 0.080 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1226 | 0.080 |
Why?
|
Prostatic Neoplasms | 3 | 2021 | 11206 | 0.080 |
Why?
|
Pyrimidines | 1 | 2020 | 3050 | 0.080 |
Why?
|
Emergency Medical Services | 1 | 2020 | 1948 | 0.080 |
Why?
|
Asthma | 3 | 2002 | 6274 | 0.080 |
Why?
|
Upper Extremity | 1 | 2013 | 682 | 0.070 |
Why?
|
Adolescent | 18 | 2024 | 89168 | 0.070 |
Why?
|
Pyridines | 2 | 2018 | 2888 | 0.070 |
Why?
|
Indoles | 1 | 2016 | 1834 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 3 | 2017 | 4077 | 0.070 |
Why?
|
Bleomycin | 3 | 2006 | 495 | 0.070 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2015 | 1126 | 0.070 |
Why?
|
Range of Motion, Articular | 1 | 2014 | 1599 | 0.070 |
Why?
|
Arsenic Poisoning | 1 | 2007 | 55 | 0.070 |
Why?
|
Watchful Waiting | 1 | 2012 | 496 | 0.070 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2007 | 72 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4534 | 0.070 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1145 | 0.070 |
Why?
|
Feasibility Studies | 5 | 2020 | 5308 | 0.070 |
Why?
|
Deoxyguanosine | 1 | 2007 | 96 | 0.070 |
Why?
|
Cities | 2 | 2021 | 546 | 0.070 |
Why?
|
Lung | 5 | 2017 | 10090 | 0.070 |
Why?
|
Health Services Research | 2 | 2013 | 1815 | 0.070 |
Why?
|
Testicular Neoplasms | 2 | 2012 | 806 | 0.070 |
Why?
|
Radiotherapy, Conformal | 3 | 2017 | 549 | 0.070 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2007 | 106 | 0.070 |
Why?
|
Algorithms | 5 | 2022 | 14158 | 0.070 |
Why?
|
Neoplasms, Second Primary | 4 | 2012 | 1062 | 0.070 |
Why?
|
Androgen Antagonists | 1 | 2016 | 1418 | 0.070 |
Why?
|
Rhinitis | 1 | 1995 | 751 | 0.070 |
Why?
|
Carbon Monoxide | 3 | 2011 | 551 | 0.070 |
Why?
|
Time Factors | 13 | 2016 | 40271 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3237 | 0.070 |
Why?
|
Pregnancy | 10 | 2012 | 30179 | 0.070 |
Why?
|
Program Development | 1 | 2013 | 1296 | 0.070 |
Why?
|
Life Expectancy | 1 | 2013 | 1249 | 0.070 |
Why?
|
Fibrosis | 1 | 2014 | 2076 | 0.070 |
Why?
|
Activities of Daily Living | 3 | 2014 | 2433 | 0.070 |
Why?
|
Occupational Exposure | 2 | 2019 | 1818 | 0.070 |
Why?
|
Alcohol-Related Disorders | 1 | 2009 | 243 | 0.070 |
Why?
|
Maximum Tolerated Dose | 3 | 2019 | 890 | 0.070 |
Why?
|
Mental Health | 1 | 2021 | 3271 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2020 | 10273 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2785 | 0.070 |
Why?
|
Triethyltin Compounds | 1 | 2005 | 4 | 0.070 |
Why?
|
Receptor, erbB-2 | 2 | 2017 | 2586 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2020 | 3985 | 0.060 |
Why?
|
Postoperative Period | 3 | 2019 | 1833 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 2 | 2006 | 2258 | 0.060 |
Why?
|
Musculoskeletal Diseases | 1 | 2012 | 601 | 0.060 |
Why?
|
Glutathione Transferase | 1 | 2007 | 567 | 0.060 |
Why?
|
Maternal Exposure | 1 | 2012 | 1078 | 0.060 |
Why?
|
Boston | 6 | 2020 | 9361 | 0.060 |
Why?
|
Preoperative Period | 2 | 2019 | 564 | 0.060 |
Why?
|
Meningioma | 1 | 2014 | 1222 | 0.060 |
Why?
|
Hospitalization | 3 | 2020 | 10845 | 0.060 |
Why?
|
Inpatients | 1 | 2016 | 2561 | 0.060 |
Why?
|
Plethysmography, Whole Body | 2 | 2001 | 25 | 0.060 |
Why?
|
Ifosfamide | 2 | 2003 | 234 | 0.060 |
Why?
|
Occupational Diseases | 1 | 2013 | 1494 | 0.060 |
Why?
|
Cause of Death | 3 | 2019 | 3727 | 0.060 |
Why?
|
Body Mass Index | 3 | 2016 | 13030 | 0.060 |
Why?
|
Patient Preference | 1 | 2012 | 948 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 1 | 2014 | 1176 | 0.060 |
Why?
|
Respiration | 1 | 2011 | 1667 | 0.060 |
Why?
|
Mutation | 7 | 2023 | 30243 | 0.060 |
Why?
|
Biopsy | 2 | 2019 | 6816 | 0.060 |
Why?
|
Peripheral Nervous System | 1 | 2005 | 151 | 0.060 |
Why?
|
Ventricular Dysfunction | 1 | 2005 | 144 | 0.060 |
Why?
|
Neoplasm Invasiveness | 3 | 2012 | 3637 | 0.060 |
Why?
|
Program Evaluation | 1 | 2013 | 2508 | 0.060 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 2040 | 0.060 |
Why?
|
Receptors, Estrogen | 1 | 2012 | 2243 | 0.060 |
Why?
|
Obesity | 3 | 2016 | 13065 | 0.060 |
Why?
|
CpG Islands | 2 | 2007 | 1209 | 0.060 |
Why?
|
Polymers | 1 | 2011 | 1631 | 0.060 |
Why?
|
Mice | 12 | 2023 | 82045 | 0.060 |
Why?
|
Ethylene Glycols | 2 | 1997 | 198 | 0.060 |
Why?
|
Airway Resistance | 2 | 2002 | 406 | 0.060 |
Why?
|
Pain Measurement | 1 | 2014 | 3577 | 0.060 |
Why?
|
Radiography, Interventional | 1 | 2011 | 1127 | 0.060 |
Why?
|
Arsenic | 1 | 2007 | 362 | 0.060 |
Why?
|
Diarrhea | 3 | 2019 | 1320 | 0.060 |
Why?
|
Methyl Ethers | 2 | 1997 | 197 | 0.060 |
Why?
|
Carcinoid Tumor | 1 | 2005 | 226 | 0.060 |
Why?
|
Particulate Matter | 2 | 2014 | 2614 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 2020 | 6241 | 0.060 |
Why?
|
Attitude to Health | 1 | 2012 | 2030 | 0.060 |
Why?
|
Phosphonoacetic Acid | 1 | 2003 | 54 | 0.050 |
Why?
|
Computer Simulation | 2 | 2017 | 6278 | 0.050 |
Why?
|
Disease Progression | 6 | 2020 | 13655 | 0.050 |
Why?
|
Laparoscopy | 1 | 2015 | 2056 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2016 | 3805 | 0.050 |
Why?
|
Neurotoxins | 1 | 2004 | 241 | 0.050 |
Why?
|
Mitomycin | 3 | 2011 | 264 | 0.050 |
Why?
|
Medical Errors | 1 | 2011 | 1263 | 0.050 |
Why?
|
Positron-Emission Tomography | 3 | 2021 | 6657 | 0.050 |
Why?
|
Diethylstilbestrol | 1 | 2003 | 87 | 0.050 |
Why?
|
Nasal Mucosa | 2 | 1997 | 412 | 0.050 |
Why?
|
Alcoholic Beverages | 1 | 2004 | 266 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2062 | 0.050 |
Why?
|
Seasons | 4 | 2020 | 1526 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4728 | 0.050 |
Why?
|
Benzene | 1 | 2003 | 107 | 0.050 |
Why?
|
Population Surveillance | 1 | 2013 | 2601 | 0.050 |
Why?
|
Body Weight | 4 | 2003 | 4630 | 0.050 |
Why?
|
Heart | 1 | 2015 | 4451 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2017 | 4340 | 0.050 |
Why?
|
Anti-Anxiety Agents | 1 | 2024 | 405 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 1993 | 2959 | 0.050 |
Why?
|
DNA Methylation | 2 | 2007 | 4421 | 0.050 |
Why?
|
Bronchitis | 2 | 2000 | 196 | 0.050 |
Why?
|
Genomics | 3 | 2023 | 5909 | 0.050 |
Why?
|
Digestive System Surgical Procedures | 2 | 2005 | 584 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3858 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1994 | 2538 | 0.050 |
Why?
|
Cognition | 1 | 2019 | 7066 | 0.050 |
Why?
|
DNA Repair | 1 | 2011 | 2051 | 0.050 |
Why?
|
Communication | 1 | 2016 | 3910 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2742 | 0.050 |
Why?
|
Environmental Health | 2 | 2019 | 295 | 0.050 |
Why?
|
Cohort Studies | 11 | 2016 | 41797 | 0.050 |
Why?
|
Informed Consent | 2 | 2012 | 1012 | 0.050 |
Why?
|
Sulfur Dioxide | 3 | 2006 | 178 | 0.050 |
Why?
|
Child | 10 | 2024 | 80863 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2022 | 2964 | 0.050 |
Why?
|
Cluster Analysis | 2 | 1999 | 2731 | 0.050 |
Why?
|
Shoulder | 2 | 2014 | 301 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4642 | 0.050 |
Why?
|
Angiotensin I | 1 | 2021 | 53 | 0.050 |
Why?
|
Vincristine | 2 | 2015 | 1039 | 0.050 |
Why?
|
Confidence Intervals | 4 | 2011 | 2932 | 0.050 |
Why?
|
Risk Factors | 14 | 2016 | 74915 | 0.050 |
Why?
|
Environmental Pollutants | 3 | 2007 | 1290 | 0.050 |
Why?
|
Uracil | 1 | 2002 | 210 | 0.040 |
Why?
|
Pandemics | 1 | 2021 | 8753 | 0.040 |
Why?
|
Cranial Nerves | 1 | 2001 | 98 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2001 | 247 | 0.040 |
Why?
|
Hong Kong | 1 | 2020 | 168 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2003 | 577 | 0.040 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2015 | 695 | 0.040 |
Why?
|
Brain | 2 | 2018 | 27438 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2012 | 3202 | 0.040 |
Why?
|
Killer Cells, Natural | 2 | 2020 | 2209 | 0.040 |
Why?
|
Income | 1 | 2009 | 1878 | 0.040 |
Why?
|
Reproducibility of Results | 8 | 2011 | 20231 | 0.040 |
Why?
|
Cementation | 1 | 2000 | 92 | 0.040 |
Why?
|
Genes, myc | 1 | 2001 | 391 | 0.040 |
Why?
|
Models, Animal | 2 | 2008 | 2126 | 0.040 |
Why?
|
Recurrence | 3 | 2023 | 8510 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2011 | 2079 | 0.040 |
Why?
|
Dacarbazine | 1 | 2022 | 560 | 0.040 |
Why?
|
Diabetes, Gestational | 1 | 2009 | 1259 | 0.040 |
Why?
|
Haplotypes | 1 | 2006 | 2725 | 0.040 |
Why?
|
Thromboxane A2 | 1 | 1999 | 88 | 0.040 |
Why?
|
Anal Canal | 1 | 2022 | 376 | 0.040 |
Why?
|
Urethra | 1 | 2021 | 406 | 0.040 |
Why?
|
Air Conditioning | 1 | 2019 | 54 | 0.040 |
Why?
|
Data Collection | 3 | 2013 | 3329 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2021 | 330 | 0.040 |
Why?
|
Neck | 2 | 2014 | 736 | 0.040 |
Why?
|
Spin Labels | 1 | 2020 | 339 | 0.040 |
Why?
|
Endotoxins | 1 | 2001 | 520 | 0.040 |
Why?
|
Cancer Care Facilities | 2 | 2013 | 424 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2020 | 370 | 0.040 |
Why?
|
Vegetables | 2 | 2015 | 1202 | 0.040 |
Why?
|
Acclimatization | 1 | 2019 | 114 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 306 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 17149 | 0.040 |
Why?
|
Genes, p53 | 1 | 2001 | 716 | 0.040 |
Why?
|
Nephrectomy | 1 | 2024 | 949 | 0.040 |
Why?
|
Age Distribution | 2 | 2018 | 2881 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2001 | 663 | 0.040 |
Why?
|
Prednisone | 2 | 2015 | 1568 | 0.040 |
Why?
|
Bone Cements | 1 | 2000 | 326 | 0.040 |
Why?
|
Nitrogen Dioxide | 3 | 2006 | 527 | 0.040 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 305 | 0.040 |
Why?
|
Bronchial Hyperreactivity | 1 | 1999 | 301 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2020 | 534 | 0.040 |
Why?
|
Epoprostenol | 1 | 1999 | 248 | 0.040 |
Why?
|
Genotype | 5 | 2014 | 13047 | 0.040 |
Why?
|
Tissue Expansion Devices | 1 | 2019 | 160 | 0.040 |
Why?
|
Contrast Media | 1 | 2011 | 5336 | 0.040 |
Why?
|
Hypokalemia | 1 | 2019 | 153 | 0.040 |
Why?
|
Mucositis | 1 | 2019 | 108 | 0.040 |
Why?
|
Head | 2 | 2014 | 927 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2019 | 2103 | 0.040 |
Why?
|
Angiotensin II | 1 | 2021 | 849 | 0.040 |
Why?
|
Microscopy, Confocal | 2 | 2015 | 1977 | 0.040 |
Why?
|
Cyclophosphamide | 2 | 2015 | 2224 | 0.040 |
Why?
|
Ovarian Neoplasms | 3 | 2012 | 4906 | 0.040 |
Why?
|
Respiratory Function Tests | 3 | 1999 | 1697 | 0.040 |
Why?
|
Ethanol | 2 | 2015 | 1334 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2020 | 322 | 0.040 |
Why?
|
Rats, Inbred F344 | 2 | 1997 | 826 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2018 | 304 | 0.040 |
Why?
|
Logistic Models | 4 | 2012 | 13324 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2024 | 3408 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2020 | 467 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2024 | 12450 | 0.030 |
Why?
|
New Hampshire | 2 | 2007 | 175 | 0.030 |
Why?
|
Turbinates | 1 | 1997 | 66 | 0.030 |
Why?
|
Ideal Body Weight | 1 | 2016 | 27 | 0.030 |
Why?
|
Massachusetts | 3 | 2019 | 8908 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2006 | 1498 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2002 | 783 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2007 | 3145 | 0.030 |
Why?
|
CA-19-9 Antigen | 1 | 2016 | 107 | 0.030 |
Why?
|
Mouth Neoplasms | 2 | 2019 | 598 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2011 | 18388 | 0.030 |
Why?
|
Equipment Design | 2 | 2015 | 3530 | 0.030 |
Why?
|
ROC Curve | 1 | 2024 | 3624 | 0.030 |
Why?
|
Perfusion | 1 | 2021 | 1402 | 0.030 |
Why?
|
Necrosis | 2 | 2018 | 1621 | 0.030 |
Why?
|
Skull | 1 | 2000 | 832 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1438 | 0.030 |
Why?
|
Genetic Variation | 1 | 2011 | 6610 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2477 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 906 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2001 | 998 | 0.030 |
Why?
|
Alcohol Drinking | 2 | 2009 | 4052 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 697 | 0.030 |
Why?
|
Nails | 2 | 2007 | 298 | 0.030 |
Why?
|
Mice, Nude | 2 | 2012 | 3635 | 0.030 |
Why?
|
Fatigue | 2 | 2018 | 1556 | 0.030 |
Why?
|
Sirolimus | 1 | 2022 | 1542 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2020 | 1390 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2012 | 1706 | 0.030 |
Why?
|
Medical Audit | 1 | 2016 | 454 | 0.030 |
Why?
|
Administration, Inhalation | 2 | 1997 | 1170 | 0.030 |
Why?
|
Petrous Bone | 1 | 1995 | 85 | 0.030 |
Why?
|
Child, Preschool | 4 | 2024 | 42623 | 0.030 |
Why?
|
Neoplasm, Residual | 2 | 2012 | 1014 | 0.030 |
Why?
|
Surgical Flaps | 2 | 1994 | 1683 | 0.030 |
Why?
|
Inhalation | 1 | 2015 | 145 | 0.030 |
Why?
|
2,4,5-Trichlorophenoxyacetic Acid | 1 | 1994 | 15 | 0.030 |
Why?
|
Levamisole | 2 | 2005 | 36 | 0.030 |
Why?
|
Biocompatible Materials | 2 | 2000 | 1703 | 0.030 |
Why?
|
Excipients | 1 | 2015 | 98 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 1 | 1995 | 210 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 9099 | 0.030 |
Why?
|
Filtration | 1 | 2015 | 228 | 0.030 |
Why?
|
Carboxylic Acids | 1 | 2015 | 91 | 0.030 |
Why?
|
Technology, Pharmaceutical | 1 | 2015 | 84 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15638 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2020 | 1251 | 0.030 |
Why?
|
Rhodamines | 1 | 2015 | 178 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11138 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2020 | 1119 | 0.030 |
Why?
|
United States Department of Agriculture | 1 | 2014 | 47 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 857 | 0.030 |
Why?
|
Pons | 1 | 1995 | 242 | 0.030 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 1995 | 255 | 0.030 |
Why?
|
Air | 1 | 2014 | 187 | 0.030 |
Why?
|
Forecasting | 2 | 2014 | 2950 | 0.030 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2015 | 275 | 0.030 |
Why?
|
Enoxaparin | 1 | 2016 | 391 | 0.030 |
Why?
|
Prednisolone | 1 | 2015 | 327 | 0.030 |
Why?
|
Glycerol | 1 | 2015 | 275 | 0.030 |
Why?
|
Laminectomy | 1 | 1995 | 226 | 0.030 |
Why?
|
Hospice Care | 1 | 2020 | 679 | 0.030 |
Why?
|
Reference Values | 1 | 2001 | 4941 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1322 | 0.030 |
Why?
|
Urban Population | 2 | 2014 | 2047 | 0.030 |
Why?
|
Dogs | 3 | 2006 | 3847 | 0.030 |
Why?
|
Anastomotic Leak | 1 | 2015 | 171 | 0.030 |
Why?
|
Fetal Resorption | 1 | 1993 | 15 | 0.030 |
Why?
|
Child Health Services | 1 | 1999 | 645 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1781 | 0.030 |
Why?
|
Malleus | 1 | 1993 | 27 | 0.030 |
Why?
|
Infant | 3 | 2024 | 36497 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2001 | 2003 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 332 | 0.030 |
Why?
|
Organs at Risk | 1 | 2015 | 368 | 0.030 |
Why?
|
Pharmaceutical Vehicles | 1 | 2012 | 57 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1973 | 0.030 |
Why?
|
Facial Nerve | 1 | 1995 | 277 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1629 | 0.030 |
Why?
|
Thinness | 1 | 2016 | 483 | 0.030 |
Why?
|
Multicenter Studies as Topic | 2 | 2012 | 1727 | 0.030 |
Why?
|
Lymphocytes | 1 | 2000 | 2611 | 0.030 |
Why?
|
Random Allocation | 1 | 1997 | 2399 | 0.030 |
Why?
|
Bile Ducts | 1 | 2014 | 288 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2674 | 0.030 |
Why?
|
Polymorphism, Genetic | 3 | 2007 | 4249 | 0.030 |
Why?
|
Medicare | 2 | 2021 | 6881 | 0.030 |
Why?
|
Models, Chemical | 1 | 1994 | 611 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2039 | 0.020 |
Why?
|
Nanomedicine | 1 | 2015 | 291 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3463 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1995 | 916 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1997 | 1339 | 0.020 |
Why?
|
Intraoperative Care | 1 | 1995 | 772 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1669 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3734 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2020 | 2434 | 0.020 |
Why?
|
Risk | 2 | 2020 | 9642 | 0.020 |
Why?
|
Facial Paralysis | 1 | 1995 | 346 | 0.020 |
Why?
|
Hepatectomy | 2 | 2014 | 588 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2067 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 1998 | 1076 | 0.020 |
Why?
|
Cotinine | 1 | 2011 | 207 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2012 | 574 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2018 | 1183 | 0.020 |
Why?
|
Embryonic and Fetal Development | 1 | 1991 | 420 | 0.020 |
Why?
|
Leukemia | 1 | 1999 | 1527 | 0.020 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2012 | 168 | 0.020 |
Why?
|
Speech Perception | 1 | 1995 | 512 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1628 | 0.020 |
Why?
|
Gases | 2 | 2001 | 204 | 0.020 |
Why?
|
Hysterectomy | 1 | 2015 | 863 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 1997 | 1395 | 0.020 |
Why?
|
Wrist | 1 | 2012 | 232 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3108 | 0.020 |
Why?
|
Postoperative Care | 2 | 2012 | 1481 | 0.020 |
Why?
|
Hospitals | 1 | 2003 | 3906 | 0.020 |
Why?
|
Bone Diseases | 1 | 1993 | 418 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2819 | 0.020 |
Why?
|
Survivors | 1 | 2020 | 2381 | 0.020 |
Why?
|
Atmosphere Exposure Chambers | 2 | 1999 | 51 | 0.020 |
Why?
|
Thromboembolism | 1 | 2016 | 1006 | 0.020 |
Why?
|
Orchiectomy | 1 | 2012 | 466 | 0.020 |
Why?
|
Monte Carlo Method | 2 | 2008 | 1262 | 0.020 |
Why?
|
Axilla | 1 | 2012 | 629 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 1999 | 1257 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7213 | 0.020 |
Why?
|
Lung Diseases | 1 | 2000 | 1926 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2010 | 166 | 0.020 |
Why?
|
Vagina | 1 | 2015 | 845 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2011 | 6135 | 0.020 |
Why?
|
Carbon | 2 | 2006 | 671 | 0.020 |
Why?
|
Victoria | 1 | 2009 | 64 | 0.020 |
Why?
|
Muscles | 1 | 1994 | 1582 | 0.020 |
Why?
|
DNA, Viral | 1 | 2016 | 2206 | 0.020 |
Why?
|
Epidemiologic Studies | 2 | 2004 | 681 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1364 | 0.020 |
Why?
|
Glioma | 1 | 2024 | 3523 | 0.020 |
Why?
|
Choice Behavior | 1 | 2015 | 846 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14728 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 9623 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 1992 | 666 | 0.020 |
Why?
|
Parathion | 1 | 2008 | 14 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 3246 | 0.020 |
Why?
|
Radiography | 1 | 2000 | 6995 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2012 | 2017 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 1999 | 1400 | 0.020 |
Why?
|
Local Government | 1 | 2009 | 83 | 0.020 |
Why?
|
Ecology | 1 | 2009 | 105 | 0.020 |
Why?
|
Comorbidity | 2 | 2015 | 10601 | 0.020 |
Why?
|
Fruit | 1 | 2014 | 1165 | 0.020 |
Why?
|
Quality Control | 1 | 2011 | 835 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2019 | 2665 | 0.020 |
Why?
|
Drug Substitution | 1 | 2011 | 291 | 0.020 |
Why?
|
Interferon-alpha | 2 | 2003 | 909 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3629 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5152 | 0.020 |
Why?
|
Demography | 1 | 2013 | 1643 | 0.020 |
Why?
|
Electromyography | 1 | 2013 | 1399 | 0.020 |
Why?
|
Heart Rate | 1 | 2019 | 4218 | 0.020 |
Why?
|
Specialization | 1 | 2013 | 782 | 0.020 |
Why?
|
Drug Carriers | 1 | 2012 | 712 | 0.020 |
Why?
|
Niacinamide | 1 | 2010 | 419 | 0.020 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 555 | 0.020 |
Why?
|
Neutrophils | 1 | 2000 | 3790 | 0.020 |
Why?
|
Lymphoma, Follicular | 1 | 2012 | 460 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2012 | 1706 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2659 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2009 | 509 | 0.020 |
Why?
|
Sulfites | 1 | 2007 | 83 | 0.020 |
Why?
|
Hippocampus | 1 | 2020 | 3783 | 0.020 |
Why?
|
Pneumonia | 1 | 1999 | 2162 | 0.020 |
Why?
|
Analgesics | 1 | 2014 | 1070 | 0.020 |
Why?
|
Workload | 1 | 2013 | 852 | 0.020 |
Why?
|
Postmenopause | 1 | 2016 | 2519 | 0.020 |
Why?
|
Mental Health Services | 1 | 1999 | 1732 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6348 | 0.020 |
Why?
|
Atrial Fibrillation | 1 | 2006 | 5162 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2012 | 7863 | 0.020 |
Why?
|
Genetic Markers | 2 | 2005 | 2604 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2010 | 532 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2012 | 1195 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1924 | 0.020 |
Why?
|
Heart Diseases | 1 | 2000 | 2816 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2013 | 1397 | 0.020 |
Why?
|
Lomustine | 1 | 2006 | 60 | 0.020 |
Why?
|
Insecticides | 1 | 2008 | 200 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1766 | 0.020 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2008 | 350 | 0.020 |
Why?
|
Collagen | 1 | 1995 | 2646 | 0.020 |
Why?
|
Missouri | 1 | 2006 | 115 | 0.020 |
Why?
|
Bone and Bones | 1 | 1997 | 2589 | 0.020 |
Why?
|
Preoperative Care | 1 | 1995 | 2257 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1995 | 6242 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7605 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4120 | 0.020 |
Why?
|
Agranulocytosis | 1 | 2005 | 98 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2656 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 2 | 1998 | 338 | 0.020 |
Why?
|
Tobacco Use Disorder | 1 | 2011 | 710 | 0.020 |
Why?
|
Decision Making | 2 | 2012 | 3961 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3665 | 0.020 |
Why?
|
Bangladesh | 1 | 2007 | 735 | 0.020 |
Why?
|
Safety | 1 | 2010 | 1159 | 0.020 |
Why?
|
Cell Count | 2 | 1999 | 1835 | 0.020 |
Why?
|
Methotrexate | 1 | 2012 | 1722 | 0.020 |
Why?
|
Streptozocin | 1 | 2005 | 195 | 0.020 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 934 | 0.020 |
Why?
|
Carcinogens | 1 | 2007 | 455 | 0.020 |
Why?
|
Spinal Fusion | 1 | 1995 | 1310 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2012 | 1734 | 0.020 |
Why?
|
Overweight | 1 | 2016 | 2428 | 0.020 |
Why?
|
Health Surveys | 2 | 2006 | 4056 | 0.020 |
Why?
|
Health Care Costs | 1 | 1998 | 3265 | 0.020 |
Why?
|
Sunburn | 1 | 2006 | 156 | 0.020 |
Why?
|
Students | 1 | 2015 | 1751 | 0.020 |
Why?
|
Benzodiazepines | 1 | 2011 | 1139 | 0.010 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 5532 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3412 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2012 | 2437 | 0.010 |
Why?
|
Tetrachloroethylene | 1 | 2004 | 7 | 0.010 |
Why?
|
Drug Approval | 1 | 2011 | 817 | 0.010 |
Why?
|
Patient Selection | 1 | 2016 | 4266 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8538 | 0.010 |
Why?
|
Central Nervous System Diseases | 1 | 2008 | 521 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2286 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3230 | 0.010 |
Why?
|
Sex Factors | 2 | 2013 | 10647 | 0.010 |
Why?
|
Apoptosis | 2 | 2015 | 9526 | 0.010 |
Why?
|
Vitamin B Complex | 1 | 2005 | 299 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2007 | 1585 | 0.010 |
Why?
|
Ventilation | 1 | 2004 | 129 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2005 | 1379 | 0.010 |
Why?
|
Baltimore | 1 | 2003 | 234 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2011 | 3619 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2003 | 6527 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5801 | 0.010 |
Why?
|
Filgrastim | 1 | 2002 | 132 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2717 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2731 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3708 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8635 | 0.010 |
Why?
|
Colonoscopy | 2 | 2002 | 1412 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3123 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2483 | 0.010 |
Why?
|
Air Movements | 1 | 2001 | 40 | 0.010 |
Why?
|
Health Promotion | 1 | 2013 | 2215 | 0.010 |
Why?
|
Water | 1 | 2007 | 1421 | 0.010 |
Why?
|
Birth Weight | 1 | 2009 | 2117 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6521 | 0.010 |
Why?
|
Biological Assay | 1 | 2004 | 629 | 0.010 |
Why?
|
Hydroxyurea | 1 | 2002 | 284 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 2179 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2006 | 1100 | 0.010 |
Why?
|
Reference Standards | 1 | 2004 | 1015 | 0.010 |
Why?
|
Lipids | 1 | 1992 | 3346 | 0.010 |
Why?
|
Anticoagulants | 1 | 2016 | 4840 | 0.010 |
Why?
|
Australia | 1 | 2004 | 1264 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2014 | 26351 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1995 | 3543 | 0.010 |
Why?
|
Bronchoalveolar Lavage | 1 | 2000 | 131 | 0.010 |
Why?
|
Gestational Age | 1 | 2009 | 3615 | 0.010 |
Why?
|
Transcription Factors | 1 | 2020 | 12174 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2005 | 998 | 0.010 |
Why?
|
Comprehension | 1 | 2006 | 641 | 0.010 |
Why?
|
Paraffin Embedding | 1 | 2001 | 306 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 823 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7956 | 0.010 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1999 | 80 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 13026 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 2007 | 9263 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2001 | 419 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 1999 | 143 | 0.010 |
Why?
|
Coal | 1 | 1999 | 122 | 0.010 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2001 | 453 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2002 | 631 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2017 | 5192 | 0.010 |
Why?
|
Macrophages, Alveolar | 1 | 2001 | 415 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2003 | 679 | 0.010 |
Why?
|
Causality | 1 | 2005 | 1255 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2000 | 882 | 0.010 |
Why?
|
Risk-Taking | 1 | 2004 | 1041 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 1996 | 15965 | 0.010 |
Why?
|
Connecticut | 1 | 1999 | 365 | 0.010 |
Why?
|
Motor Vehicles | 1 | 2000 | 282 | 0.010 |
Why?
|
Phenotype | 2 | 2007 | 16712 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1999 | 413 | 0.010 |
Why?
|
Chlordan | 1 | 1997 | 5 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6091 | 0.010 |
Why?
|
Mental Recall | 1 | 2004 | 1226 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 3922 | 0.010 |
Why?
|
Ovalbumin | 1 | 1999 | 678 | 0.010 |
Why?
|
Colectomy | 1 | 2003 | 700 | 0.010 |
Why?
|
Drug Interactions | 1 | 2002 | 1421 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14766 | 0.010 |
Why?
|
Colonic Polyps | 1 | 2002 | 557 | 0.010 |
Why?
|
Materials Testing | 1 | 2000 | 871 | 0.010 |
Why?
|
Urban Health | 1 | 1999 | 535 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2002 | 2863 | 0.010 |
Why?
|
Gene Amplification | 1 | 2001 | 1091 | 0.010 |
Why?
|
Observer Variation | 1 | 2003 | 2622 | 0.010 |
Why?
|
Perception | 1 | 2003 | 1207 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2006 | 2139 | 0.010 |
Why?
|
Patient Compliance | 1 | 2005 | 2696 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2001 | 1751 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 1997 | 1007 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23638 | 0.010 |
Why?
|
Pesticides | 1 | 1997 | 299 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2000 | 1561 | 0.010 |
Why?
|
Eosinophils | 1 | 1999 | 955 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 9066 | 0.010 |
Why?
|
Administration, Oral | 1 | 2002 | 4041 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4479 | 0.010 |
Why?
|
Brain Damage, Chronic | 1 | 1994 | 266 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 1999 | 1510 | 0.010 |
Why?
|
Health Status | 1 | 2006 | 4096 | 0.010 |
Why?
|
Drug Monitoring | 1 | 1999 | 964 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1999 | 3438 | 0.010 |
Why?
|
Pilot Projects | 1 | 2006 | 8730 | 0.010 |
Why?
|
Epithelium | 1 | 1997 | 1610 | 0.010 |
Why?
|
Phosphatidylglycerols | 1 | 1992 | 34 | 0.010 |
Why?
|
Physical Examination | 1 | 1998 | 1262 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2002 | 2339 | 0.010 |
Why?
|
Inflammation | 2 | 2002 | 10865 | 0.010 |
Why?
|
Allergens | 1 | 1999 | 1445 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1999 | 2216 | 0.010 |
Why?
|
Atrophy | 1 | 1997 | 1648 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 1998 | 1320 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 16029 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2005 | 3826 | 0.010 |
Why?
|
Adenoma | 1 | 2002 | 2163 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 1994 | 993 | 0.010 |
Why?
|
Phosphatidylcholines | 1 | 1992 | 406 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2009 | 26395 | 0.010 |
Why?
|
Bone Transplantation | 1 | 1994 | 925 | 0.010 |
Why?
|
Blood Vessels | 1 | 1994 | 1112 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1992 | 1543 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1999 | 8201 | 0.000 |
Why?
|
Phospholipids | 1 | 1992 | 783 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2006 | 22293 | 0.000 |
Why?
|
Guideline Adherence | 1 | 1998 | 2239 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1997 | 1668 | 0.000 |
Why?
|
Cytokines | 1 | 2001 | 7449 | 0.000 |
Why?
|
Ischemia | 1 | 1994 | 1900 | 0.000 |
Why?
|
Vascular Surgical Procedures | 1 | 1994 | 1509 | 0.000 |
Why?
|
Coronary Disease | 1 | 2000 | 5926 | 0.000 |
Why?
|
Rabbits | 1 | 1991 | 4786 | 0.000 |
Why?
|
Surgical Wound Infection | 1 | 1994 | 1544 | 0.000 |
Why?
|
Chronic Disease | 1 | 1999 | 9382 | 0.000 |
Why?
|
Graft Survival | 1 | 1994 | 3890 | 0.000 |
Why?
|
Reoperation | 1 | 1993 | 4342 | 0.000 |
Why?
|
Cholesterol | 1 | 1992 | 2910 | 0.000 |
Why?
|
Age Factors | 1 | 1999 | 18478 | 0.000 |
Why?
|
Proteins | 1 | 1992 | 6008 | 0.000 |
Why?
|
Carcinoma, Bronchogenic | 1 | 1976 | 87 | 0.000 |
Why?
|
Intestinal Polyps | 1 | 1976 | 105 | 0.000 |
Why?
|
Radioimmunoassay | 1 | 1976 | 862 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1976 | 385 | 0.000 |
Why?
|
Liver Regeneration | 1 | 1976 | 214 | 0.000 |
Why?
|
Genital Neoplasms, Female | 1 | 1976 | 539 | 0.000 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1976 | 959 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1976 | 1207 | 0.000 |
Why?
|
Colitis, Ulcerative | 1 | 1976 | 1930 | 0.000 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1976 | 2254 | 0.000 |
Why?
|